Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06035757
PHASE4

The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery

Sponsor: Konkuk University Medical Center

View on ClinicalTrials.gov

Summary

The present trial conducted to demonstrate the administration of sugammadex as reversal of neuromuscular blockade agent reduces the incidence of emergence agitation (EA) comparing to neostigmine

Official title: The Effect of Administration of Sugammadex on the Occurrence of Emergence Agitation in Pediatric Strabismus Surgery-prospective Randomized Controlled Trial

Key Details

Gender

All

Age Range

4 Years - 7 Years

Study Type

INTERVENTIONAL

Enrollment

76

Start Date

2023-12-01

Completion Date

2026-03-30

Last Updated

2026-03-03

Healthy Volunteers

Yes

Interventions

DRUG

Bridion 200 MG in 2 ML Injection

Sugammadex is administered at the end of surgery after assessment of the level of neuromuscular blockade is done. The dosage of each reversal agent is determined with response to TOF or PTC.

DRUG

Pyridostigmine Bromide 5 MG/ML

Pyridostigmine is administered at the end of surgery after assessment of the level of neuromuscular blockade is done. The dosage of each reversal agent is determined with response to TOF.

Locations (1)

Konkuk University Medical Center

Seoul, Seoul-T'ǔkpyǒlshi, South Korea